241 related articles for article (PubMed ID: 5934795)
1. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
[No Abstract] [Full Text] [Related]
2. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
[No Abstract] [Full Text] [Related]
4. Combined therapy of L1210 leukemia with Damvar and cytostatics.
Pujman V; Cernochová S
Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
[TBL] [Abstract][Full Text] [Related]
5. Offsetting toxicity of antineoplastic agents.
Cook ES; Nutini LG; Fardon JC; Proudfoot MB; Poydock ME
J Surg Oncol; 1975; 7(5):337-45. PubMed ID: 1100914
[TBL] [Abstract][Full Text] [Related]
6. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
Pouillart P; Huong TH; Lhéritier J
Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
[No Abstract] [Full Text] [Related]
7. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
[No Abstract] [Full Text] [Related]
8. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M; Sakurai Y
Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
[No Abstract] [Full Text] [Related]
9. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
Osswald H; Herrmann R; Youssef M
Cancer Lett; 1985 Dec; 29(3):277-82. PubMed ID: 4075296
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VII.
Venditti JM; Sheldon DR; Goldin A
Cancer Res; 1964 Jan; 24(1 Pt 1):145-210. PubMed ID: 5878215
[No Abstract] [Full Text] [Related]
11. Potentiation of the antitumor activity of methotrexate by concurrent infusion of thymidine.
Semon JH; Grindey GB
Cancer Res; 1978 Sep; 38(9):2905-11. PubMed ID: 679199
[No Abstract] [Full Text] [Related]
12. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
Roberts D; Hilliard SL
Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
[No Abstract] [Full Text] [Related]
13. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
Kim K; Blechman WJ; Riddle VG; Pardee AB
Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
[TBL] [Abstract][Full Text] [Related]
14. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
Pouillart R; Huong TH; Brugerie E; Lheritier J
Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870
[No Abstract] [Full Text] [Related]
15. Rationale of chemotherapeutic adjuvant treatment.
Goldin A
Arch Geschwulstforsch; 1978; 48(7):627-35. PubMed ID: 736743
[No Abstract] [Full Text] [Related]
16. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
Kline I
Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
[No Abstract] [Full Text] [Related]
17. Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules.
Kline I; Venditti JM; Tyrer DD; Goldin A
Cancer Res; 1966 May; 26(5):853-9. PubMed ID: 5936445
[No Abstract] [Full Text] [Related]
18. Effects of priming dose schedules in methotrexate treatment of mouse leukemia L1210.
Straus MJ; Mantel N; Goldin A
Cancer Res; 1971 Oct; 31(10):1429-33. PubMed ID: 5095131
[No Abstract] [Full Text] [Related]
19. Effects of allopurinol on the therapeutic efficacy of methotrexate.
Grindey GB; Moran RG
Cancer Res; 1975 Jul; 35(7):1702-5. PubMed ID: 1131828
[TBL] [Abstract][Full Text] [Related]
20. High molecular weight derivatives of methotrexate as chemotherapeutic agents.
Chu BC; Whiteley JM
Mol Pharmacol; 1977 Jan; 13(1):80-8. PubMed ID: 834187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
